Daron Evans, CEO of Specialty Renal Product at Nephros, holds 203.35K shares in Rezolute (Ticker: RZLT), holds 160.42K shares in Nephros (Ticker: NEPH). Most recently, Daron Evans Bought ― shares of Rezolute on Jun 14, 2024 for an estimated value of 161.20K.
What is the percentage of profitable transactions made by Daron Evans?
The percentage of profitable transactions made by Daron Evans is 75%.
What is the average return per transaction made by Daron Evans?
The average return per transaction made by Daron Evans is 62.70%.
What stocks does Daron Evans hold?
Daron Evans holds: NEPH, RZLT stocks.
What was Daron Evans’s latest transaction?
Daron Evans latest transaction was an Informative Buy of $161.20K.
What was Daron Evans's most profitable transaction?
Daron Evans’s most profitable transaction was an Informative Buy of RZLT stock on February 20, 2024. The return on the trade was 284.80%.
What is Daron Evans's role in Nephros?
Daron Evans's role in Nephros is CEO of Specialty Renal Product.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.